Morepen Lab launches wide range of products to fight COVID-19
Nidhi JaniCategories: Trending
Last week, the company had received a license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller for its Baddi plant in Himachal Pradesh and thereafter, it’s working to commercialise the production of HCQ, in both API as well as in the form of tablets.
New Delhi-based Morepen Laboratories has launched a wide range of essential products, required to combat the growing menace of COVID-19 and to further prevent the spread of this disease in the country.
The range of products include non-contact infrared thermometers, alcohol-based hand sanitisers, hand wash, hand rubs and face masks, all under its umbrella brand-Dr Morepen.
Last week, the company had received a license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller for its Baddi plant in Himachal Pradesh and thereafter, it’s working to commercialise the production of HCQ, in both API as well as in the form of tablets.
HCQ is a prescription-based drug, which is commonly being recommended to Corona patients, who is currently under treatment. India is a leading supplier of HCQ and is supplying the product in every nook and corner of the world, including USA.
Cheering this development, the stock of Morepen Laboratories jumped 10 per cent today and locked in upper circuit of Rs 16.07. The stock had hit 52-week high of Rs 24 as on September 24, 2019 and 52-week low of Rs 7.21 as on March 23, 2020 on BSE.